Informed consent and assent guide for paediatric clinical trials in Europe
Authors:
Open Access
- 1 December 2021
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 107 (6) , 582-590
Abstract
Objective Clinical trial sponsors spend considerable resources preparing informed consent (IC) and assent documentation for multinational paediatric clinical trial applications in Europe due to the limited and dispersed patient populations, the variation of national legal and ethical requirements, and the lack of detailed guidance. The aim of this study was to design new easy-to-use guide publicly available on European Medicines Agency’s, Enpr-EMA website for all stakeholders. Methods Current EU legal, ethical and regulatory guidance for paediatric clinical trials were collated, analysed and divided into 30 subject elements in two tables. The European Network of Young Person’s Advisory Group reviewed the data and provided specific comments. A three-level recommendation using ‘traffic light’ symbols was designed for four age groups of children, according to relevance and the requirements. Results A single guide document includes two tables: (1) general information and (2) trial-specific information. In the age group of 6–9 years old, 92% of the trial-specific subject elements can be or should be included in the IC discussion. Even in the youngest possible age group (2–5 years old children), the number of elements considered was, on average, 52%. Conclusion The EU Clinical Trial Regulation (2014) does not contain specific requirements exclusively for paediatric clinical trials. This work is the first to extensively collate all the current legal, regulatory and ethical documentation on the IC process, together with input from adolescents. This guide may increase the ethical standards in paediatric clinical trials.Keywords
This publication has 13 references indexed in Scilit:
- Frameworks for Evaluating Medicines in ChildrenClinical Therapeutics, 2017
- Roles of Clinical Research Networks in Pediatric Drug DevelopmentClinical Therapeutics, 2017
- Informed consent for paediatric clinical trials in EuropeArchives of Disease in Childhood, 2016
- Public and patient involvement in paediatric researchArchives of Disease in Childhood - Education & Practice Edition, 2016
- Parents' and young people's involvement in designing a trial of ventilator weaningNursing in Critical Care, 2015
- Clinical Trial Application in Europe: What Will Change with the New Regulation?Science and Engineering Ethics, 2015
- A European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA)Archives of Disease in Childhood, 2011
- Considerations in the Rational Design and Conduct of Phase I/II Pediatric Clinical Trials: Avoiding the Problems and PitfallsClinical Pharmacology & Therapeutics, 2007
- Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use.2005
- Clinical Trials in ChildrenPediatric Drugs, 2000